Skip To Main Content

All Resources

Sort by
  • Topics
  • Format
What Are the Benefits of Screening?

Benefits of Screening

People identified early through screening programs have milder disease and better quality of life compared to control

Exploring the Etiology of Autoimmune Type 1 Diabetes

Exploring the Etiology of Autoimmune Type 1 Diabetes

Overview of the factors playing a role in the etiology of T1D.

Monitoring Individuals with IAb Positive Status

Monitoring Individuals with IAb Positive Status

Explore how clinical outcomes are impacted by screening and monitoring

Islet Autoantibodies in T1D

Islet Autoantibodies in T1D

The number, type, and titer of islet autoantibodies detected in T1D screening tests provide valuable information about potential progression to clinical T1D. 

A Guide to T1D Screening Tests

A Guide to T1D Screening Tests

A guide to autoimmune type 1 diabetes (T1D) screening tests.

IDS 2024 Symposium Summary

IDS 2024 Symposium Summary

At the BR1DGE symposium at IDS 2024, leading experts shared new insights on the mechanisms driving autoimmune type 1 diabetes (T1D), emphasizing the benefits of genetic risk scoring, and the latest biomarker research.  

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

ISPAD 2024 Symposium Summary

ISPAD 2024 Symposium Summary

At the BR1DGE symposium at ISPAD 2024, leading experts shared their insights on the importance of screening for islet autoantibodies (IAb) to identify early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D). Early identification, followed by monitoring and education, is crucial to help prepare people for a life with T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

BR1DGE Symposium at EASD 2024

BR1DGE Symposium at EASD 2024

At the BR1DGE symposium at EASD 2024, leading experts shared new insights on early-stage (Stage 1 and 2) autoimmune type 1 diabetes (T1D), emphasizing the importance of screening for islet antibodies (IAbs) together with monitoring and education. Early type 1 diabetes identification can help to prepare people for a life with T1D.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform.

T1D vs T2D: Key Differences in Adults

T1D vs T2D: Key Differences in Adults

An infographic exploring how to differentiate T1D from T2D, which is essential to prevent misdiagnosis and associated complications.  

The Stages of Type 1 Diabetes

The Stages of Type 1 Diabetes

Explore the stages of type 1 diabetes

Providing Psychosocial Care for Individuals with Presymptomatic Autoimmune T1D

Providing Psychosocial Care for Individuals with Presymptomatic Autoimmune T1D

Learn about the psychosocial impacts of type 1 diabetes and explore expert guidance on how to integrate psychosocial care into routine care.

Type 1 Diabetes: Mechanism of Beta Cell Loss Caused by Autoimmune T Cells

Type 1 Diabetes: Mechanism of Beta Cell Loss Caused by Autoimmune T Cells

This animated video provides an overview of the key immunological processes that underlie the development of autoimmunity in T1D. Autoreactive T cells drive pancreatic beta-cell destruction, resulting in insulin deficiency and, ultimately, hyperglycemia and symptoms of T1D.